PMID- 15301907
OWN - NLM
STAT- MEDLINE
DCOM- 20041223
LR  - 20060712
IS  - 0167-5273 (Print)
IS  - 0167-5273 (Linking)
VI  - 96
IP  - 3
DP  - 2004 Sep
TI  - Fulminant myocarditis successfully treated with high-dose immunoglobulin.
PG  - 485-6
AB  - Fulminant myocarditis is characterized by the rapid development of 
      life-threatening congestive heart failure. Intravenous immunoglobulin (IVIG), by 
      modulating the immune response, may be used for the treatment of acute 
      myocarditis. We report two children with fulminant myocarditis successfully 
      treated with a 10-h infusion of high-dose IVIG. In those cases, a dramatic 
      clinical improvement was achieved, with both cardiac enzymes and myocardial 
      function normalized within 1-2 weeks after treatment.
FAU - Kim, Hae Soon
AU  - Kim HS
FAU - Sohn, Sejung
AU  - Sohn S
FAU - Park, Ji Yun
AU  - Park JY
FAU - Seo, Jeong Wan
AU  - Seo JW
LA  - eng
PT  - Case Reports
PT  - Letter
PL  - Netherlands
TA  - Int J Cardiol
JT  - International journal of cardiology
JID - 8200291
RN  - 0 (Immunoglobulins, Intravenous)
SB  - IM
MH  - Acute Disease
MH  - Child
MH  - Dose-Response Relationship, Drug
MH  - Female
MH  - Humans
MH  - Immunoglobulins, Intravenous/*administration & dosage
MH  - Myocarditis/*drug therapy
EDAT- 2004/08/11 05:00
MHDA- 2004/12/24 09:00
CRDT- 2004/08/11 05:00
PHST- 2003/03/17 00:00 [received]
PHST- 2003/05/02 00:00 [accepted]
PHST- 2004/08/11 05:00 [pubmed]
PHST- 2004/12/24 09:00 [medline]
PHST- 2004/08/11 05:00 [entrez]
AID - S016752730300531X [pii]
AID - 10.1016/j.ijcard.2003.05.037 [doi]
PST - ppublish
SO  - Int J Cardiol. 2004 Sep;96(3):485-6. doi: 10.1016/j.ijcard.2003.05.037.